7-N-[(2-methyl-1,3-benzoxazol-5-yl)methyl]-3-sulfanylidene-5-N-[(1S)-5-(2H-tetrazol-5-yl)-2,3-dihydro-1H-inden-1-yl]-2H-[1,2,4]triazolo[4,3-a]pyrimidine-5,7-dicarboxamide

C26H21N11O3S — CID 91247974

IUPAC7-N-[(2-methyl-1,3-benzoxazol-5-yl)methyl]-3-sulfanylidene-5-N-[(1S)-5-(2H-tetrazol-5-yl)-2,3-dihydro-1H-inden-1-yl]-2H-[1,2,4]triazolo[4,3-a]pyrimidine-5,7-dicarboxamide
SMILESCc1nc2cc(CNC(=O)c3cc(C(=O)N[C@H]4CCc5cc(-c6nn[nH]n6)ccc54)n4c(=S)[nH]nc4n3)ccc2o1
InChIInChI=1S/C26H21N11O3S/c1-12-28-18-8-13(2-7-21(18)40-12)11-27-23(38)19-10-20(37-25(30-19)33-34-26(37)41)24(39)29-17-6-4-14-9-15(3-5-16(14)17)22-31-35-36-32-22/h2-3,5,7-10,17H,4,6,11H2,1H3,(H,27,38)(H,29,39)(H,34,41)(H,31,32,35,36)/t17-/m0/s1
InChIKeyKTCXKNFZBOIOIU-KRWDZBQOSA-N
MW567.60 g/mol
LogP2.76
Rot. Bonds6

About 7-N-[(2-methyl-1,3-benzoxazol-5-yl)methyl]-3-sulfanylidene-5-N-[(1S)-5-(2H-tetrazol-5-yl)-2,3-dihydro-1H-inden-1-yl]-2H-[1,2,4]triazolo[4,3-a]pyrimidine-5,7-dicarboxamide

7-N-[(2-methyl-1,3-benzoxazol-5-yl)methyl]-3-sulfanylidene-5-N-[(1S)-5-(2H-tetrazol-5-yl)-2,3-dihydro-1H-inden-1-yl]-2H-[1,2,4]triazolo[4,3-a]pyrimidine-5,7-dicarboxamide (PubChem CID 91247974) has the molecular formula C26H21N11O3S and a molecular weight of 567.60 g/mol. Its IUPAC name is 7-N-[(2-methyl-1,3-benzoxazol-5-yl)methyl]-3-sulfanylidene-5-N-[(1S)-5-(2H-tetrazol-5-yl)-2,3-dihydro-1H-inden-1-yl]-2H-[1,2,4]triazolo[4,3-a]pyrimidine-5,7-dicarboxamide.

Molecular Properties

Compound Name7-N-[(2-methyl-1,3-benzoxazol-5-yl)methyl]-3-sulfanylidene-5-N-[(1S)-5-(2H-tetrazol-5-yl)-2,3-dihydro-1H-inden-1-yl]-2H-[1,2,4]triazolo[4,3-a]pyrimidine-5,7-dicarboxamide
PubChem CID91247974
Molecular FormulaC26H21N11O3S
Molecular Weight567.60 g/mol
Exact Mass567.15
IUPAC Name7-N-[(2-methyl-1,3-benzoxazol-5-yl)methyl]-3-sulfanylidene-5-N-[(1S)-5-(2H-tetrazol-5-yl)-2,3-dihydro-1H-inden-1-yl]-2H-[1,2,4]triazolo[4,3-a]pyrimidine-5,7-dicarboxamide
SMILESCc1nc2cc(CNC(=O)c3cc(C(=O)N[C@H]4CCc5cc(-c6nn[nH]n6)ccc54)n4c(=S)[nH]nc4n3)ccc2o1
InChIInChI=1S/C26H21N11O3S/c1-12-28-18-8-13(2-7-21(18)40-12)11-27-23(38)19-10-20(37-25(30-19)33-34-26(37)41)24(39)29-17-6-4-14-9-15(3-5-16(14)17)22-31-35-36-32-22/h2-3,5,7-10,17H,4,6,11H2,1H3,(H,27,38)(H,29,39)(H,34,41)(H,31,32,35,36)/t17-/m0/s1
InChIKeyKTCXKNFZBOIOIU-KRWDZBQOSA-N
XLogP2.76
TPSA184.67 Ų
H-Bond Donors4
H-Bond Acceptors11
Rotatable Bonds6
Heavy Atoms41
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500567.60
LogP ≤ 52.76
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze 7-N-[(2-methyl-1,3-benzoxazol-5-yl)methyl]-3-sulfanylidene-5-N-[(1S)-5-(2H-tetrazol-5-yl)-2,3-dihydro-1H-inden-1-yl]-2H-[1,2,4]triazolo[4,3-a]pyrimidine-5,7-dicarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 7-N-[(2-methyl-1,3-benzoxazol-5-yl)methyl]-3-sulfanylidene-5-N-[(1S)-5-(2H-tetrazol-5-yl)-2,3-dihydro-1H-inden-1-yl]-2H-[1,2,4]triazolo[4,3-a]pyrimidine-5,7-dicarboxamide?
The IUPAC name of 7-N-[(2-methyl-1,3-benzoxazol-5-yl)methyl]-3-sulfanylidene-5-N-[(1S)-5-(2H-tetrazol-5-yl)-2,3-dihydro-1H-inden-1-yl]-2H-[1,2,4]triazolo[4,3-a]pyrimidine-5,7-dicarboxamide (CID 91247974) is 7-N-[(2-methyl-1,3-benzoxazol-5-yl)methyl]-3-sulfanylidene-5-N-[(1S)-5-(2H-tetrazol-5-yl)-2,3-dihydro-1H-inden-1-yl]-2H-[1,2,4]triazolo[4,3-a]pyrimidine-5,7-dicarboxamide.
What is the SMILES notation for 7-N-[(2-methyl-1,3-benzoxazol-5-yl)methyl]-3-sulfanylidene-5-N-[(1S)-5-(2H-tetrazol-5-yl)-2,3-dihydro-1H-inden-1-yl]-2H-[1,2,4]triazolo[4,3-a]pyrimidine-5,7-dicarboxamide?
The canonical SMILES for 7-N-[(2-methyl-1,3-benzoxazol-5-yl)methyl]-3-sulfanylidene-5-N-[(1S)-5-(2H-tetrazol-5-yl)-2,3-dihydro-1H-inden-1-yl]-2H-[1,2,4]triazolo[4,3-a]pyrimidine-5,7-dicarboxamide is Cc1nc2cc(CNC(=O)c3cc(C(=O)N[C@H]4CCc5cc(-c6nn[nH]n6)ccc54)n4c(=S)[nH]nc4n3)ccc2o1.
What is the InChIKey of 7-N-[(2-methyl-1,3-benzoxazol-5-yl)methyl]-3-sulfanylidene-5-N-[(1S)-5-(2H-tetrazol-5-yl)-2,3-dihydro-1H-inden-1-yl]-2H-[1,2,4]triazolo[4,3-a]pyrimidine-5,7-dicarboxamide?
The InChIKey is KTCXKNFZBOIOIU-KRWDZBQOSA-N. The full InChI is InChI=1S/C26H21N11O3S/c1-12-28-18-8-13(2-7-21(18)40-12)11-27-23(38)19-10-20(37-25(30-19)33-34-26(37)41)24(39)29-17-6-4-14-9-15(3-5-16(14)17)22-31-35-36-32-22/h2-3,5,7-10,17H,4,6,11H2,1H3,(H,27,38)(H,29,39)(H,34,41)(H,31,32,35,36)/t17-/m0/s1.
What are the key properties of 7-N-[(2-methyl-1,3-benzoxazol-5-yl)methyl]-3-sulfanylidene-5-N-[(1S)-5-(2H-tetrazol-5-yl)-2,3-dihydro-1H-inden-1-yl]-2H-[1,2,4]triazolo[4,3-a]pyrimidine-5,7-dicarboxamide?
7-N-[(2-methyl-1,3-benzoxazol-5-yl)methyl]-3-sulfanylidene-5-N-[(1S)-5-(2H-tetrazol-5-yl)-2,3-dihydro-1H-inden-1-yl]-2H-[1,2,4]triazolo[4,3-a]pyrimidine-5,7-dicarboxamide has a molecular weight of 567.60 g/mol, XLogP of 2.76, 6 rotatable bonds, 4 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 7-N-[(2-methyl-1,3-benzoxazol-5-yl)methyl]-3-sulfanylidene-5-N-[(1S)-5-(2H-tetrazol-5-yl)-2,3-dihydro-1H-inden-1-yl]-2H-[1,2,4]triazolo[4,3-a]pyrimidine-5,7-dicarboxamide is sourced from PubChem (CID 91247974), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).